Indraprastha Medical Corporation Management Change
Mr. Shivakumar Pattabhiraman has completed his two-year tenure as Managing Director of Indraprastha Medical Corporation Ltd. He ceased to hold the position effective November 4, 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Mr. Shivakumar Pattabhiraman has completed his two-year tenure as Managing Director of Indraprastha Medical Corporation Ltd. He ceased to hold the position effective November 4, 2026.
Indraprastha Medical reported Q2FY27 revenue from operations of Rs 412.85 crore and PAT of Rs 53.58 crore. Half-year PAT rose to Rs 109.43 crore from Rs 100.92 crore a year earlier.
Indraprastha Medical Corporation will hold a board meeting on 29 Oct 2026 to consider Q1 FY27 unaudited standalone financial results. The trading window is closed from 1 Oct to 31 Oct 2026.